Welcome to Reference Page for CancerPDF

Title PMID
Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases. 27186406
Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer. 27058005
Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer. 27043541
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study. 27026199
Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay. 26993605
High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera. 26992070
Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling. 26783151
Identification of novel serum peptides biomarkers for female breast cancer patients in Western China. 26705257
Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer. 26662807
Tumor size, stage and grade alterations of urinary peptidome in RCC. 26482227
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression. 26379225
Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study. 26376850
Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patients. 26282206
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. 25910294
Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma. 25368985
The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer. 25233230
Liquid chromatography-mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis. 25168216
Deciphering the peptidome of urine from ovarian cancer patients and healthy controls. 24982608
Deciphering the ovarian cancer ascites fluid peptidome. 24694173
Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. 24618180
Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer. 24565027
Detection of cervical cancer biomarker patterns in blood plasma and urine by differential scanning calorimetry and mass spectrometry. 24416269
Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. 24289627
Biomarkers screening between preoperative and postoperative patients in pancreatic cancer. 23991970
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling. 23915341
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. 23915185
Peptidome analysis of human skim milk in term and preterm milk. 23891694
Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides. 23667664
Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. 23586861
Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. 23091368
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients. 22942358
Toward a standardized saliva proteome analysis methodology. 22809520
Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC). 22628229
Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. 22521044
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks. 22086897
Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer. 21805675
Serum peptidome profiling in patients with gastric cancer. 21739109
Human urinary peptide database for multiple disease biomarker discovery. 21591268
[Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS]. 21575517
A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. 21533267
Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. 21267442
The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients. 21137033
Specific Investigation of Sample Handling Effects on Protease Activities and Absolute Serum Concentrations of Various Putative Peptidome Cancer Biomarkers. 21124649
Serum peptidome profiling in patients with lung cancer. 21082738
Soluble plasma HLA peptidome as a potential source for cancer biomarkers. 20974924
Finding new posttranslational modifications in salivary proline-rich proteins. 20879038
Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. 19795908
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation. 19762145
Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling. 19728888
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme. 19674866
An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. 21136997
Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. 19482289
Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. 19470732
Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. 17269714
Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. 16896061
Differential exoprotease activities confer tumor-specific serum peptidome patterns. 16395409